- Home
- AMRN vs JRI Comparison
AMRN vs JRI Comparison
Compare AMRN & JRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMRN | JRI |
|---|---|---|
| Founded | 1989 | 2012 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.8M | 359.8M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMRN | JRI |
|---|---|---|
| Price | $14.89 | $13.03 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 83.3K | ★ 112.9K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.38% |
| EPS Growth | ★ 55.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $181,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.22 | N/A |
| 52 Week Low | $12.96 | $11.67 |
| 52 Week High | $20.90 | $14.37 |
Technical Indicators
Market Signals| Indicator | AMRN | JRI |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 58.23 |
| Support Level | $14.76 | $12.45 |
| Resistance Level | $15.09 | $13.04 |
| Average True Range (ATR) | 0.80 | 0.14 |
| MACD | -0.17 | 0.03 |
| Stochastic Oscillator | 9.43 | 78.12 |
Price Performance
Historical ComparisonAbout AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
About JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest
Nuveen Real Asset Income and Growth Fund is a closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.